The #European healthcare regulator said it had recommended conditionally approving @GileadSciences' antiviral treatment, remdesivir, for use in #coronavirus patients.https://t.co/QVjXYGktQh
— The Jerusalem Post (@Jerusalem_Post) June 25, 2020
Source: Twitter
Discover more from #News247WorldPress
Subscribe to get the latest posts sent to your email.